NEOGEN CHEMICALS cash flow

Latest FY26

Cash from operations: −₹231cr₹196 cr in FY25
Capital spending: ₹556cr+74.9% on FY25
Free cash flow: −₹787cr−₹122 cr in FY25
Cash from financing: ₹642cr+467.5% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	27.5	27.8	22.9	16.2
	—	75.1	48.5	42.1	28.9
	—	−4.1	0.0	−7.3	0.0
	—	0.0	0.0	0.0	1.2
	—	1.8	1.8	−1.0	5.0
	—	0.0	−0.2	0.0	0.0
	—	0.8	0.0	0.0	0.0
	—	3.0	14.1	0.0	−5.3
	—	−259	−120	−89.5	−98.4
	—	−183	78.7	−104	−67.0
	—	−4.2	29.2	−36.2	−30.1
	—	−1.1	−2.9	−3.3	0.0
	—	−108	−7.6	17.9	0.0
	—	1.9	18.3	3.2	0.0
	—	177	113	−10.9	53.2
	—	3.8	−43.0	75.8	0.0
	—	3.1	−1.6	−0.1	0.0
	—	10.5	0.2	9.6	6.7
	—	2.5	0.4	9.1	0.0
	—	0.0	1.8	0.0	−0.4
	—	0.0	0.9	0.0	0.0
Cash from operating activities
	49.6	41.1	50.0	52.6	70.9
	—	−253	160	−72.0	−89.8
	—	−212	210	−19.4	−18.8
	—	0.0	−1.5	0.0	0.0
	—	19.7	12.3	9.8	11.5
	—	−231	196	−29.2	−30.4
Cash from investing activities
	—	556	318	303	102
	—	0.0	0.0	0.0	1.3
	—	−0.0	0.5	0.0	0.0
	—	0.0	0.5	0.0	0.0
	—	1.0	0.0	0.0	0.0
	—	175	0.0	0.0	0.0
	—	176	0.0	0.0	0.0
	—	0.0	0.0	−3.5	0.0
	—	0.0	0.0	76.4	0.0
	—	3.5	1.1	7.3	4.5
	—	140	0.0	0.0	4.8
	—	−410	−317	−216	−94.5
Cash from financing activities
	—	−0.8	0.0	247	0.0
	—	835	244	66.6	226
	—	67.1	71.8	35.3	90.0
	—	13.5	6.3	0.0	0.0
	—	—	—	−8.1	0.0
	—	109	47.8	1.4	28.9
	—	2.6	5.3	7.5	6.9
	—	0.0	0.0	−40.6	0.0
	—	642	113	237	100
	—	−0.0	−7.5	−8.2	−24.5
	—	−0.0	−7.5	−8.2	−24.5
	—	4.9	5.0	12.5	20.7
Reference items
	154	138	136	110	112
	16.6%	16.0%	17.5%	15.9%	16.3%
	−787	−787	−122	−332	−134
	—	−133	2.9	−302	—
	−₹298.40	−₹298.40	−₹46.14	−₹125.82	−₹50.83
	—	−8.05×	5.63×	−0.82×	−0.61×
	—	19.7	12.3	9.8	11.5
	—	109	47.8	1.4	28.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NEOGEN₹2,261.70

NEOGEN CHEMICALS LTD.

· Chemicals

₹ CrorePeersTATACHEM AETHER NFL LXCHEM PRIVISCL RAIN RALLIS RCFMcap ₹5,966 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	16.2	22.9	27.8	27.5	—
+ Finance Costs	28.9	42.1	48.5	75.1	—
+ Interest Income	0.0	-7.3	0.0	-4.1	—
+ Fair Value (Gains) / Losses	1.2	0.0	0.0	0.0	—
+ Unrealised FX (Gain) / Loss	5.0	-1.0	1.8	1.8	—
+ Undistributed Profits of Associates	0.0	0.0	-0.2	0.0	—
+ Other Non-cash Items	0.0	0.0	0.0	0.8	—
+ Other Reconciling Items	-5.3	0.0	14.1	3.0	—
Changes in Working Capital
+ Inventories	-98.4	-89.5	-120.2	-259.2	—
+ Trade Receivables — Current	-67.0	-104.3	78.7	-183.1	—
+ Other Financial Assets — Current	-30.1	-36.2	29.2	-4.2	—
+ Other Financial Assets — Non-current	0.0	-3.3	-2.9	-1.1	—
+ Other Current Assets	0.0	17.9	-7.6	-108.3	—
+ Other Non-current Assets	0.0	3.2	18.3	1.9	—
+ Trade Payables — Current	53.2	-10.9	113.2	177.1	—
+ Other Financial Liabilities — Current	0.0	75.8	-43.0	3.8	—
+ Other Financial Liabilities — Non-current	0.0	-0.1	-1.6	3.1	—
+ Other Current Liabilities	6.7	9.6	0.2	10.5	—
+ Other Non-current Liabilities	0.0	9.1	0.4	2.5	—
+ Provisions — Current	-0.4	0.0	1.8	0.0	—
+ Provisions — Non-current	0.0	0.0	0.9	0.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	70.9	52.6	50.0	41.1	49.6
+ Total Adjustments (incl. Working Capital)	-89.8	-72.0	159.8	-252.9	—
Cash from Operations (pre-tax)	-18.8	-19.4	209.8	-211.8	—
+ Interest Received — Operating	0.0	0.0	-1.5	0.0	—
+ Income Taxes Paid	11.5	9.8	12.3	19.7	—
Cash from Operating Activities	-30.4	-29.2	196.0	-231.5	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	102.5	302.8	317.7	555.7	—
+ Acq of Intangible Assets	1.3	0.0	0.0	0.0	—
+ Disp of Fixed Assets	0.0	0.0	0.5	-0.0	—
+ Acq of Investment Property	0.0	0.0	0.5	0.0	—
+ Disp of Other Long-term Assets	0.0	0.0	0.0	1.0	—
+ Purchase of Investments (Equity / Debt)	0.0	0.0	0.0	175.0	—
+ Disp of Interests in Joint Ventures	0.0	0.0	0.0	176.0	—
+ Acq of Subsidiaries / Businesses (net)	0.0	-3.5	0.0	0.0	—
+ Loans & Advances Repaid	0.0	76.4	0.0	0.0	—
+ Interest Received — Investing	4.5	7.3	1.1	3.5	—
+ Other Inflows / (Outflows) — Investing	4.8	0.0	0.0	140.0	—
Cash from Investing Activities	-94.5	-215.6	-316.6	-410.3	—
Cash from Financing Activities
+ Proceeds from Other Equity Instruments	0.0	246.7	0.0	-0.8	—
+ Proceeds from Borrowings	226.1	66.6	244.3	834.9	—
+ Repayment of Borrowings	90.0	35.3	71.8	67.1	—
+ Payment of Lease Liabilities	0.0	0.0	6.3	13.5	—
+ Payment of Finance Lease Liabilities	0.0	-8.1	—	—	—
+ Interest Paid	28.9	1.4	47.8	109.2	—
+ Dividends Paid	6.9	7.5	5.3	2.6	—
+ Other Inflows / (Outflows) — Financing	0.0	-40.6	0.0	0.0	—
Cash from Financing Activities	100.3	236.5	113.1	641.7	—
Net Changes in Cash (pre-FX)	-24.5	-8.2	-7.5	-0.0	—
Net Changes in Cash	-24.5	-8.2	-7.5	-0.0	—
Closing Cash	20.7	12.5	5.0	4.9	—
Reference Items
EBITDA	111.6	110.1	136.3	137.6	154.0
EBITDA Margin %	16.27	15.93	17.53	15.96	16.64
Free Cash Flow (CFO − Capex)	-134.1	-331.9	-121.7	-787.2	-787.2
Free Cash Flow to Equity	—	-302.0	2.9	-132.5	—
Free Cash Flow per Basic Share	-50.83	-125.82	-46.14	-298.40	-298.40
Cash Flow to Net Income	-0.61	-0.82	5.63	-8.05	—
Cash Paid for Taxes	11.5	9.8	12.3	19.7	—
Cash Paid for Interest	28.9	1.4	47.8	109.2	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.